Treasury Chief Reeves Intends Targeted Measures on Living Costs in Upcoming Budget
Chancellor Reeves has revealed she is planning "specific steps to tackle cost of living challenges" in the upcoming Budget.
During an interview with the BBC, she noted that lowering price rises is a joint responsibility of both the administration and the central bank.
The United Kingdom's price growth is projected to be the most elevated among the G7 advanced economies this calendar year and next.
Possible Utility Bill Interventions
Reports indicate the administration could intervene to reduce utility costs, for example by reducing the current 5% rate of VAT charged on energy.
An additional approach is to reduce some of the regulatory levies currently included in household expenses.
Fiscal Constraints and Expert Expectations
The government will receive the latest draft from the official forecaster, the OBR, on the start of the week, which will show how much room there is for such actions.
The consensus from most economists is that the Chancellor will have to introduce tax rises or spending cuts in order to adhere to her self-imposed fiscal targets.
Earlier on Thursday, estimates indicated there was a £22bn deficit for the chancellor to address, which is at the more modest range of expectations.
"It is a joint job between the Bank of England and the administration to bear down further on some of the sources of price increases," Reeves informed the BBC in Washington, at the yearly gatherings of the IMF and global financial institution.
Revenue Commitments and Global Concerns
While a great deal of the focus has been on probable tax rises, the Treasury chief said the latest figures from the fiscal watchdog had not changed her commitment to campaign commitments not to raise rates on income tax, VAT or National Insurance.
She attributed an "uncertain world" with growing geopolitical and commercial tensions for the Budget revenue measures, probably to be directed on those "most able to pay."
Global Trade Disputes
Commenting on apprehensions about the United Kingdom's commercial links with China she said: "Our national security invariably take priority."
Recent declaration by Chinese authorities to tighten trade restrictions on rare earths and other resources that are crucial for high-technology manufacturing led US President the US President to suggest an extra 100% import tax on goods from China, increasing the possibility of an full-scale commercial conflict between the two global powers.
The US Treasury Secretary called China's action "commercial pressure" and "a global supply chain control attempt."
Inquired about considering the US offer to join its dispute with China, Reeves said she was "deeply worried" by Chinese actions and urged the Chinese government "to avoid restrictions and limit trade."
She said the decision was "damaging for the world economy and generates further obstacles."
"I believe there are fields where we should confront Chinese policies, but there are also valuable opportunities to sell into China's economy, including banking sector and other areas of the economic system. We've got to achieve that balance correct."
The chancellor also affirmed she was cooperating with international partners "on our own critical minerals strategy, so that we are less reliant."
NHS Medicine Pricing and Funding
The Chancellor also acknowledged that the cost the NHS spends on drugs could rise as a result of current discussions with the US government and its pharmaceutical firms, in exchange for reduced taxes and investment.
A number of the biggest global pharmaceutical manufacturers have said lately that they are either halting or abandoning projects in the United Kingdom, with several attributing the insufficient payments they are obtaining.
Last month, the government science advisor said the cost the NHS spends on drugs would need to go up to prevent companies and pharmaceutical investment leaving the United Kingdom.
Reeves told media: "It has been observed as a result of the cost structure, that medical research, recent pharmaceuticals have not been offered in the United Kingdom in the way that they are in other EU nations."
"We want to guarantee that people getting treatment from the National Health Service are able to receive the finest critical medicines in the globe. And so we are looking at these issues, and... looking to obtain additional investment into the UK."